Lanthanum Carbonate Modulates Inflammatory Profile in Hemodialysis Patients: Relationship with Fibroblast Growth Factor-23
Elevated fibroblast growth factor 23 (FGF-23) is independently associated with increased inflammatory markers in chronic kidney disease. Lanthanum carbonate (LaCa) reduces FGF-23. We studied the effects of LaCa on inflammatory profile of hemodialysis patients, and the relationship with changes in FG...
Main Authors: | J.F. Navarro-González, J. Donate-Correa, M. Muros, P. García-García, M.A. Getino, J. García-Pérez, C. Mora-Fernández |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2013-01-01
|
Series: | European Journal of Inflammation |
Online Access: | https://doi.org/10.1177/1721727X1301100108 |
Similar Items
-
Pathophysiological Implications of Imbalances in Fibroblast Growth Factor 23 in the Development of Diabetes
by: Javier Donate-Correa, et al.
Published: (2021-06-01) -
Role of sclerostin, fibroblast growth factor-23, and Klotho in hemodialysis patients
by: Azza A I. Elmenyawi, et al.
Published: (2019-01-01) -
Does fibroblast growth factor 23 correlates with volume status in hemodialysis patients?
by: Farzanehsadat Minoo, et al.
Published: (2019-10-01) -
Correlation between Fibroblast Growth Factor 23 and C-reactive Protein in Hemodialysis Patients
by: Elham Ramezanzade, et al.
Published: (2022-03-01) -
Changes in Fibroblast Growth Factor 23 and Soluble Klotho Levels After Hemodialysis Initiation
by: Chiaki Kawabata, et al.
Published: (2020-01-01)